Fmoc-AEEA-OH

Published date: 2025-11-28 13:45:56

Fmoc-AEEA-OH Structure
Share to Facebook Share to Twitter Share to Linkedin
Name Fmoc-8-amino-3,6-dioxaoctanoic acid CAS# 166108-71-0
Price $Inquiry/1kg Purity 99.0%
Stocking
Period
Inquiry Stock In Stock
Product Webpage: https://www.congenpharma.com/Produc/Fmoc-AEEA-OH.html
 Detail Product Information
Fmoc-AEEA-OH Chemical Name: 2-{2-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethoxy]ethoxy}acetic acid :

Synonyms:8-(9-Fluorenylmethoxycarbonylamino)-3,6-dioxaoctanoic acid

2-(2-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)ethoxy)acetic acid
Fmoc-8-amino-3,6-dioxaoctanoicacid,
Fmoc-AEEA;
Fmoc-PEG2-aceticacid;
{2-[2-(Fmoc-amino)ethoxy]ethoxy}aceticacid≥99%(HPLC);
Fmoc-NH-(PEG)-COOH(9atoms)Novabiochem;
9-FLUORENYLMETHOXYCARBONYL-8-AMINO-3,6-DIOXAOCTANOICACID;
8-(FMOC-AMINO)-3,6-DIOXA-OCTANOICACID;
EC number:805-205-6

SMILES code:OC(=O)COCCOCCNC(=O)OCC1C2=C(C=CC=C2)C2=C1C=CC=C2


CongenPharma: Your Trusted Partner in Peptide Building Blocks — Featuring Our Advantage Product: Fmoc-AEEA-OH

About CongenPharma

Established in 2013, CongenPharma is a high-tech enterprise integrating R&D, production, and sales. With our owned R&D center and factory located in Guangzhou, China, we are dedicated to providing high-quality pharmaceutical intermediates and peptide building blocks to the global pharmaceutical and biotech industry.

Backed by solid scientific expertise and a strict quality control system, CongenPharma has become a trusted and core part of the supply chain for numerous global partners.

Fmoc-AEEA-OH is an advantage product of CongenPharma. It serves as a critical spacer/linker in the solid-phase peptide synthesis of GLP-1 receptor agonists such as Semaglutide and Tirzepatide.

Why Choose CongenPharma's Fmoc-AEEA-OH?

Exceptional Purity, Guaranteed Quality:

Consistently high purity of 99%+ minimizes side reactions during peptide synthesis, ensuring the high quality and consistency of the final API.

Advanced Manufacturing, Stable Supply:

Leveraging our owned factory and R&D center, we maintain strict control over the entire production chain from raw materials to finished products. This ensures robust processes and enables reliable, large-scale, continuous supply.

Application-Optimized, Technically Advanced:

Our product is specially optimized for the synthesis of cutting-edge peptides like Semaglutide and Tirzepatide. It helps improve peptide chain solubility and spatial conformation, thereby enhancing synthesis efficiency.

Expert Support, Collaborative Partnership:

We provide comprehensive technical documentation and professional customer support, working alongside our clients to overcome R&D and manufacturing challenges.

Key Applications:

Semaglutide

Tirzepatide

Other GLP-1 analogues and long-chain therapeutic peptides.

In stock:200KG
More

Supplier/Manufacture

Guangzhou Congen Pharmatec Co.,Ltd.

Chemsrc Level: Unverified
Tel: 020-13380081396
Address: Room 206, Building G12, South China Advanced Materials Innovation Park, No. 31 Kefeng Road, Huangpu Dist. Guangzhou,China
Area: China
Contact: Shine Huang
Contact Phone #: 13380081396
Email: marketing@congenpharm.com
Website: https://www.congenpharm.com/
Major Market: Domestic, Southeast Asia, Africa, Europe, South America, North America
Annual Trade Volume:
Foreign Trade % of Sales:
Major partners:
CongenPharma
Founded in 2013 and headquartered in Guangzhou, CongenPharma specializes in pharmaceutical peptide intermediates, cosmetic peptides and ingredients. With our EMPHASES® synthesis platform, we have become a trusted manufacturer in the peptide industry, serving over 500 customers worldwide.

We owned a 2,000+ sqm R&D center and pilot lab with two manufacturing facilities—one fully operational and another under construction. CongenPharma has applied for over 40 patents with 30 granted (USA and Japan) and over 100 trademarks with 74 approved.

Our New LPPS – EMPHASES® Peptide Synthesis Technology uses soluble carriers to replace traditional insoluble solid-phase resin, enabling fast reaction speeds, reduced consumption (amino acids, reagents, and solvents), simplified post-processing and broad applicability. This innovative platform ensures high purity, excellent efficacy and lower-cost peptide synthesis, while supporting green and sustainable peptide synthesis.
Please see website:www.congenpharma.com
Top Suppliers:




Get all suppliers by the below link:

Fmoc-8-amino-3,6-dioxaoctanoic acid suppliers


Price: ¥550/100 mg
Price from the other suppliers:
2024-07-15 Fmoc-8-amino-3,6-dioxaoctanoic acid
Price: Inquiry
2021-02-24 Fmoc-AEEA
Price: ¥Inquiry
2016-10-24 Fmoc-8-amino-3,6-dioxaoctanoic acid
Price: ¥70.0
2021-07-26 [2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic acid
Price: $Inquiry
2018-08-11 Fmoc-mini-PEG
Price: ¥Inquiry
2018-09-12 Fmoc-AEEA
Price: ¥Inquiry
2019-09-06 Fmoc-AEEA
Price: ¥Inquiry
2017-06-13 Fmoc-8-amino-3,6-dioxaoctanoic acid
Price: ¥Inquiry
2024-04-29 Fmoc-8-amino-3,6-dioxaoctanoic acid
Price: ¥Inquiry

Get all price from the following link:

Fmoc-8-amino-3,6-dioxaoctanoic acidprice